1. BET INHIBITOR RG6146, VENETOCLAX, AND RITUXIMAB IS A HIGHLY ACTIVE REGIMEN IN RELAPSED/REFRACTORY (R/R) DLBCL: INITIAL REPORT OF PHASE 1B SAFETY, BIOMARKER, AND RESPONSE DATA. (12th June 2019) Authors: Dickinson, M.; Briones Mejjide, J.; Herrera, A.F.; González Barca, E.; Ghosh, N.; Cordoba, R.; Rutherford, S.C.; Advani, R.; Bournazou, E.; Labriola‐Tompkins, E.; Friess, T.; Chesne, E.; Brouwer‐Visser, J.; Lechner, K.; Brennan, B.; Nueesch, E.; De Mario, M.; Hutchings, M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. INTERIM RESULTS FROM a PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN IN COMBINATION WITH NIVOLUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA. (June 2017) Authors: Herrera, A.F.; Moskowitz, A.J.; Bartlett, N.L.; Vose, J.M.; Ramchandren, R.; Feldman, T.A.; Lacasce, A.S.; Ansell, S.M.; Moskowitz, C.H.; Fenton, K.; Ogden, C.; Taft, D.; Zhang, Q.; Kato, K.; Campbell, M.; Advani, R.H. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PET‐ADAPTED NIVOLUMAB +/‐ ICE AS INITIAL SALVAGE THERAPY IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA. (12th June 2019) Authors: Herrera, A.F.; Chen, R.; Palmer, J.; Tsai, N.; McBride, K.; Song, J.; Mei, M.; Zain, J.; Nikolaenko, L.; Popplewell, L.; Nademanee, A.; Rosen, S.; Kwak, L.; Lee, H.; Forman, S. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. POLATUZUMAB VEDOTIN PLUS BENDAMUSTINE AND RITUXIMAB OR OBINUTUZUMAB IN RELAPSED/REFRACTORY FL OR DLBCL: UPDATED RESULTS OF A PHASE 1B/2 STUDY. (June 2017) Authors: Matasar, M.; Herrera, A.F.; Kamdar, M.; Mehta, A.; Assouline, S.; Fleury, I.; Kim, T.M.; Kim, W.S.; Bosch, F.; Radford, J.; Flowers, C.R.; Bu, L.; Hong, W.; Sehn, L.H. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. REAL‐WORLD BENDAMUSTINE USE IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (R/R DLBCL). (12th June 2019) Authors: Herrera, A.F.; Ogbu, U.; Ku, G.; Chuo, C.Y. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 428 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗